While SMAD4 is normally expressed in breast cancer where we have shown that BMP4 has anti-metastatic activity [8], in colorectal and pancreatic cancers where a pro-tumor role of BMP4 is observed [23, 24], SMAD4 is mutated or lost in up to 40% of cases [25]. This evidence concerns the gene SMAD4 and breast carcinoma.